KOLKATA: Even as clinical trials have been crucial part of development of drugs, vaccines and medical equipment for years, it was Covid-19 pandemic that brought this stream of science into the fore. With the growing need for trained manpower in this field the Peerless Skill Academy (PSA) as all set to churn out clinical trial associates. The academy set up in collaboration with Ramakrishna Math and Mission (RKM) to promote vocational training programs has launched a one year diploma course under the Life Science Sector Skill Development Council, ministry of skill development and entrepreneurship.
“Any graduate in Bio Sciences or pharma graduates or medical graduates including MBBS and alternative medicine streams who have the zing for clinical research can apply for this one year course. We intend to start the session by April end or May beginning,” said Peerlees Hospital clinical director research and academics Dr Subhrojyoti Bhowmick.
You have successfully cast your vote
The course is expected to provide hands on experience to make these students competent to be part of clinical trials for pharmaceutical companies, contract research organisations or research laboratories.
“Given the ever increasing number of clinical trials across the country there is the need for qualified and trained manpower. There is huge employment opportunity in this field. I am happy that such course which is accredited is going start in Kolkata,” said Dr Subhodeep Sinha senior VP and medical director with the Hyderabad based Hetero Labs.
During the one year course students will have six months theory and practical sessions. After this they will be sent for apprenticeship during which they will get a stipend of Rs 9000 a month under the government of India’s National Apprenticeship Program for at least six months leading to diploma.
“RKM that runs various vocational courses has tied up with PSA for this course and our hospital will also be facilitating in the training part. We will begin the course with an 30 students,” said Dr Sujit Kar Purkayastha managing director Peerless Hospital. During the pandemic the hospital has been proactively involved in clinical trials including that of Sputnik V vaccine and drugs like Tocilizumab and nitric oxide nasal spray.